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Abstract
Background: Ocular abnormalities present in microcephalic infants with presumed Zika virus (ZIKV) congenital
disease includes focal pigment mottling of the retina, chorioretinal atrophy, optic nerve abnormalities, and lens
dislocation. Target cells in the ocular compartment for ZIKV infectivity are unknown. The cellular response of ocular
cells to ZIKV infection has not been described. Mechanisms for viral dissemination in the ocular compartment of
ZIKV-infected infants and adults have not been reported. Here, we identify target cells for ZIKV infectivity in both
the inner and outer blood-retinal barriers (IBRB and OBRB), describe the cytokine expression profile in the IBRB after
ZIKV exposure, and propose a mechanism for viral dissemination in the retina.
Methods: We expose primary cellular components of the IBRB including human retinal microvascular endothelial cells,
retinal pericytes, and Müller cells as well as retinal pigmented epithelial cells of the OBRB to the PRVABC56 strain of
ZIKV. Viral infectivity was analyzed by microscopy, immunofluorescence, and reverse transcription polymerase chain
reaction (RT-PCR and qRT-PCR). Angiogenic and proinflammatory cytokines were measured by Luminex assays.
Results: We find by immunofluorescent staining using the Flavivirus 4G2 monoclonal antibody that retinal endothelial
cells and pericytes of the IBRB and retinal pigmented epithelial cells of the OBRB are fully permissive for ZIKV infection
but not Müller cells when compared to mock-infected controls. We confirmed ZIKV infectivity in retinal endothelial
cells, retinal pericytes, and retinal pigmented epithelial cells by RT-PCR and qRT-PCR using ZIKV-specific oligonucleotide
primers. Expression profiles by Luminex assays in retinal endothelial cells infected with ZIKV revealed a marginal
increase in levels of beta-2 microglobulin (β2-m), granulocyte macrophage colony-stimulating factor (GMCSF),
intercellular adhesion molecule 1 (ICAM-1), interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP1), and vascular
cell adhesion molecule 1 (VCAM-1) and higher levels of regulated upon activation, normal T cell expressed and
presumably secreted (RANTES) but lower levels of interleukin-4 (IL-4) compared to controls.
Conclusions: Retinal endothelial cells, retinal pericytes, and retinal pigmented epithelial cells are fully permissive for
ZIKV lytic replication and are primary target cells in the retinal barriers for infection. ZIKV infection of retinal endothelial
cells and retinal pericytes induces significantly higher levels of RANTES that likely contributes to ocular inflammation.
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Background
Zika virus (ZIKV) is an arbovirus that belongs to the Fla-
vivirus family which also includes West Nile virus, den-
gue, yellow fever, and Japanese encephalitis viruses and
is transmitted to humans by Aedes species mosquitoes
[1, 2]. ZIKV was first identified in a rhesus monkey in
1947 and first recognized in humans in 1952 [1, 3].
ZIKV has quickly spread to more than 70 countries in
the Americas and the Caribbean infecting more than 2
million people [4, 5]. Currently, there is no treatment or
vaccine for Zika virus. There is very limited information
known about this emerging global health threat.
ZIKV infection has been associated with a sporadic in-
crease in the incidence of microcephaly in infants [6–9].
Congenital ocular findings concomitant with microceph-
aly have also been associated with ZIKV infection during
pregnancy [10–13]. A recent study showed ocular abnor-
malities present in 34.5% of microcephalic infants exam-
ined and involved the bilateral vision in 70% of them [10].
The lesions included focal pigment mottling of the retina,
chorioretinal atrophy, optic nerve abnormalities, bilateral
iris coloboma (congenital fissure), and lens dislocation
[10]. These lesions are considered vision-threatening, and
children should be screened as a process of differential
diagnosis to rule out other causes such as West Nile virus
infection, toxoplasmosis, cytomegalovirus, rubella, herpes
simplex virus, and syphilis [13, 14]. Children born to
mothers with little or no symptoms of ZIKV infection can
still have microcephalic babies with severe ocular abnor-
malities [15]. This finding would support the notion of
ophthalmic screening for all babies born in epidemic re-
gions. Risk factors for ocular involvement in infants with
presumed ZIKV congenital infection include smaller ceph-
alic diameters at birth and infants whose mother develop
symptoms during the first trimester of pregnancy [16].
Adults with acute ZIKV disease often experience
hyperemic sclera, conjunctivitis, and retro-orbital
pain, and uveitis has also been observed in a patient
with ZIKV infection after an initial clinical presenta-
tion of conjunctival hyperemia [17–19]. The target
cells for ZIKV-associated ocular disease are unknown.
The cytokine dysregulation that contributes to ZIKV-
induced ocular inflammation is yet to be identified. The
route of viral dissemination in the ocular compartment
has not been described. Here, we identify target cells in
both the inner and outer blood-retinal barriers (IBRB and
OBRB), describe the cytokine expression profile in retinal
endothelial cells after ZIKV exposure, and propose a
mechanism for viral dissemination in the retina.
Methods
Cells
Human primary retinal microvascular endothelial cells
and retinal pericytes were obtained from Cell Systems
Corporation (Kirkland, WA, USA) and were cultivated in
Pericyte Media (PM) from ScienCell (Carlsbad, CA, USA).
Primary human retinal pigmented epithelial cells and epi-
thelial cell media (EpiCM) were obtained from ScienCell.
The human Müller cell line MIO-M1 [20], derived from
an adult retina, was kindly provided by Dr. John Penn
(Vanderbilt University Medical Center Eye Institute).
Acquisition of the MIO-M1 cell line was approved by
the Internal Review Board and Ethics Committee of
Vanderbilt University Medical Center in Nashville,
Tennessee. Retinal pericytes and retinal endothelial
cells were maintained at passage level 3 in PM media.
The Müller cell line MIO-M1 was maintained in Dul-
becco’s Modified Eagle Medium (DMEM) supple-
mented with 10% fetal bovine serum, 1% Pen/Strep.
All cells were trypsinized and plated in uncoated 100-
cm2 dishes or uncoated 4.2-cm2 glass chamber slides
at a density of and 2.5 × 105 cells per dish and well,
respectively.
Viruses and virus cultivation
The Zika virus strain PRVABC59 provided by the Centers
for Disease Control and Prevention (CDC) used in this
study was originally isolated from a human serum speci-
men from Puerto Rico in December 2015, nucleotide
(GenBank):KU501215 ZIKV strain PRVABC59, complete
genome [21–23]. The virus was cultivated in Vero cells
(Cercopithecus aethiops, African green monkey kidney cell
line), and infectious supernatant was filtered using a 0.22-
μm filter and the serum content adjusted to 15%. Viral
titers were done by end-point dilution and infectivity mea-
sured by IFA staining with the 4G2 antibody (fluorescent
focus assay (FFA) on Vero cells. Stock viral titer was ad-
justed to ~1 × 106 FFU/5 μl of infectious culture super-
natant. Heat-killed ZIKV was prepared by heating the
viral inoculum at 65 °C for 30 min in a water bath [24].
The mild heat inactivation that we employ is unlikely to
cause a global effect on thermolabile viral proteins. All
experiments were carried out under biosafety level 2 con-
tainment as recommended. The use of ZIKV was ap-
proved by the Meharry Medical College Institutional
Biosafety Committee.
Antibody validation
ZIKV-infected Vero cells were used to validate the mono-
clonal antibody to the Flavivirus group antigen which binds
to the fusion loop at the extremity of domain II of the E
protein (D1-4G2-4-15, 4G2) (Millipore, Temecula, CA,
USA) [25, 26]. ZIKV cytopathology in Vero cells included
cell rounding and sloughing with a perinuclear staining
profile using the 4G2 antibody by immunofluorescent
staining (data not shown).
Roach and Alcendor Journal of Neuroinflammation  (2017) 14:43 Page 2 of 12
Immunofluorescence
Immunofluorescent staining was performed as previously
described [27]. Briefly, chamber slide cultures containing
ZIKV-infected or mock-infected retinal endothelial cells,
retinal pericytes, Müller cells, or retinal pigmented epithe-
lial cells were washed twice with PBS pH 7.4, air-dried,
and fixed in absolute methanol for 10 min. Cells were air-
dried for 15 min, hydrated in Tris-buffered saline (pH 7.4)
for 5 min, and incubated separately for 1 h with monoclo-
nal antibodies to von Willebrand factor (VWF) for retinal
endothelial cells (Millipore, Temecula, CA, USA), or
vimentin for retinal pigmented epithelial cells (Santa Cruz,
CA, USA). All antibodies were diluted 1:50 in PBS pH 7.4.
For ZIKV infection of retinal endothelial cells, retinal peri-
cytes, Müller cells, and retinal pigmented epithelial cells,
cells were incubated for 1 h with monoclonal antibodies
to the 4G2 Flavivirus group antigen, at a 1:50 dilution in
PBS pH 7.4. Donkey anti-mouse secondary antibodies
conjugated to fluorescein isothiocyanate (FITC) were used
to detect ZIKV-positive cells. Immunofluorescent staining
was performed as previously described [27].
RT-PCR
Total RNA was extracted from both ZIKV-infected retinal
endothelial cells and retinal pigmented epithelial cells
along with their respective mock-infected and heat-killed
ZIKV control cells using a Qiagen RNeasy Mini Kit (Qia-
gen, Valencia, CA, USA). RNA was DNase-treated prior
to elution on the column according to the manufacturer’s
recommendations. Messenger RNA in 0.5 μg of each sam-
ple was primed using oligo-dT and reverse-transcribed
with a high-capacity complementary DNA (cDNA) re-
verse transcription kit (Applied Biosystems, Foster City,
CA, USA). Gene-specific primer pairs included ZIKV
forward primer 5′TTYGAAGCCCTTGGATTCTT3′ and
ZIKV reverse primer 5′CYCGGCCAATCAGTTCATC3′
and 50 ng of cDNA for RT-PCR amplification, using
PuReTaq Ready-To-Go PCR beads (GE Healthcare, Buck-
inghamshire, UK). PCR was carried out in a MJ Mini ther-
mal cycler (Bio-Rad Laboratories, Hercules, CA, USA) in
a final volume of 25 μl. The cycling protocol used was 95 °
C for 5 min, 55 °C for 30 s, and 72 °C for 1 min for 36 cy-
cles, with a final extension at 72 °C for 10 min. PCR prod-
ucts were electrophoresed in 1.5% agarose and DNA
bands visualized by ethidium bromide. Primers for
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
forward primer 5′-TGATGACATCAAGAAGGTGGT-
GAA-3′ and reverse primer 5′-TCCTTGGAGGCCA
TGTGGGC CAT-3′ (256 bp) were amplified in mock
and infected cells as a loading and quality control.
Using ZIKV-infected cell total RNA, we amplified a
364-bp DNA fragment with the above primers, re-
spectively, to positions 1538-1558 and 1902-1883 of
the ZIKV genome sequence AY632535 [28].
qRT-PCR
Total RNA was extracted separately from ZIKV-infected
retinal endothelial cells, retinal pericytes, and Müller
cells, along with the respective mock-infected controls
using a Qiagen RNeasy Mini Kit (Qiagen, Valencia, CA,
USA) as previously described above. Messenger RNA in
0.5 μg of each sample was primed using oligo-dT and
reverse-transcribed with a high-capacity cDNA reverse
transcription kit (Applied Biosystems, Foster City, CA,
USA). Real-time quantitative PCR was performed on
iCycler using iQ Sybr Green Supermix (Bio-Rad). Sam-
ples were analyzed in triplicate and normalized to GAPDH
RNA. Reaction mixture contained 250 nM of each primer
and 200 to 400 ng of template cDNA in a final volume of
20 μl. The primers specific for ZIKV were as follows: for-
ward 5′-AGGATCATAGGTGATGAAGAAAAGT-3′ and
reverse 5′-CCTGACAACACTAAGATTGGTGC-3′ [28].
RANTES primers used for qRT-PCR were as follows:
forward 5′-GGCAGCCCTCGCTGTCATCCTCA-3′, re-
verse 5′-CTTGATGTGGGCACGGGGCAGTG-3′. GAP
DH primers used for qRT-PCR were as follows: forward 5′-
GAAGGTGAAGGTCGGAGT-3′ and reverse 5′-GAAG
ATGGTGATGGGATTTC-3′.
Luminex assays
The inflammatory and angiogenic cytokine analysis was
performed with 200 μl of supernatant from three pooled
cultures of mock-infected, ZIKV-infected, and heat-killed
ZIKV-exposed retinal endothelial cells for 96 h post-
exposure using a Luminex instrument (Luminex Corpor-
ation, Austin, TX) and 100-plate viewer software. Luminex
analysis on 47 different proinflammatory and angiogenic
cytokines was performed on supernatants as previously de-
scribed [29]. Infections were performed in triplicate in
chamber slides for 96 h. Replicate assays are inherent in the
Luminex technology by counting 50 bead replicates per an-
alyte and reporting the median. This is the equivalent of
running 50 replicate assays per well. In addition, robotic
pipetting was performed for all volume-critical steps, which
minimizes well-to-well variability, and calibrators and con-
trols were run in duplicate involving three levels of control
per analyte in duplicate on every plate [30]. Experiments
presented in this study that involved ZIKV infections were
performed in triplicate. Supernatants from mock-infected,
ZIKV-infected, and heat-killed ZIKV-exposed retinal endo-
thelial cells were separately taken from triplicate samples
and pooled for Luminex analysis.
Statistical analysis
Experiments presented in this study were performed in
triplicate (mock-infected, ZIKV-infected, and heat-killed
ZIKV-exposed retinal endothelial cells, retinal pericytes,
Müller cells, and retinal pigmented epithelial cells were
used for RT-PCR and qRT-PCR amplification of ZIKV
Roach and Alcendor Journal of Neuroinflammation  (2017) 14:43 Page 3 of 12
and RANTES cDNA). To compare the mean values
between the two groups, the unpaired t test was used.
Statistical significance was defined as P < 0.05. Data are
presented as means ± SD. qRT-PCR experiments were
replicated three times and normalized to glyceraldehyde
3-phosphate dehydrogenase (GAPDH).
Results
Retinal endothelial and retinal pericytes are permissive
for ZIKV infectivity but not retinal Müller cells
To identify target cells for ZIKV infection in the eye, we
first examined cellular components of the retinal vascu-
lar unit that represents the IBRB and is a gateway to the
retina. We exposed primary human retinal microvascu-
lar endothelial cells, retinal pericytes, and Müller cells to
ZIKV at a multiplicity of infection (MOI) of 0.1 for 96 h.
In mock-infected controls, we observed the normal
cobblestone morphology of the retinal endothelial cells
in confluent monolayer cultures (Fig. 1a). Retinal endo-
thelial cells stained positive for the endothelial cell bio-
marker von Willebrand factor with strong staining of
Weibel-Palade bodies (Fig. 1b). In retinal endothelial
cells exposed to ZIKV, we observed cytopathic effects
that included rounding and sloughing of cells with
patches of the monolayer floating in the media (Fig. 1c).
We confirmed ZIKA infectivity for retinal endothelial
cells by immunofluorescent staining using the 4G2
monoclonal antibody in 96 h after infection (Fig. 1d).
Virus-infected retinal endothelial cells showed a peri-
nuclear staining profile with the 4G2 antibody (Fig. 1d).
The 4G2 antibody was validated for reactivity in ZIKV-
infected Vero cells (data not shown).
We then compared endothelial cell infectivity for ZIKV
with retinal pericytes and Müller cells (Fig. 2a-1–a-12).
Retinal endothelial cells were found to be highly permis-
sive for ZIKV (Fig. 2a-1–a-3) and showed cytopathic ef-
fects that included cells lysis, rounding and sloughing of
cells with a more cytoplasmic staining profile when com-
pared with ZIKV-infected retinal pericytes (Fig. 2a-5–a-7).
Müller cells (Fig. 2a-9–a-11) were shown not to be per-
missive for ZIKV infection and did not exhibit ZIKV cyto-
pathic effects 96 h after infection and stained negative
with the 4G2 antibody (Fig. 2a-8, 2a-9). Mock-infected
controls of retinal endothelial cells, retinal pericytes, and
Müller cells stained with the 4G2 antibody are shown in
Fig. 2a-4, a-8, a-12, respectively. We then examined ZIKV
Fig. 1 ZIKV infectivity of primary human retinal endothelial cells. Phase contrast images of a an uninfected confluent monolayer of retinal
endothelial cells, b a confluent monolayer of retinal endothelial cells staining positive for von Willebrand factor (VWF), and c retinal endothelial
cells 96 h after infection with the ZIKV. Immunofluorescence staining of ZIKV-infected endothelial cells after 96 h with the Flavivirus 4G2 antibody.
d All images were taken on a Nikon TE2000S microscope mounted with a charge-coupled device (CCD) camera at ×200 magnification. For fluorescent
images, 4′,6-diamidino-2-phenylindole (DAPI) was used to stain the nuclei blue
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messenger RNA (mRNA) expression by qRT-PCR over a
time course of 24 and 96 h and 8 days after in retinal
endothelial cells, retinal pericytes, and Müller cells
(Fig. 2b). We observed the highest level of ZIKV mRNA
expression by qRT-PCR in pericytes compared to that in
retinal endothelial cells, and no ZIKV mRNA expression
in Müller cells (Fig. 2b). Normalized fold expression desig-
nated as ND refers to ZIKV transcripts not detected via
amplification. In addition, the normal fold expression
levels for Müller cells exposed to ZIKV in 24 and 96 h are
a result of low CT values below threshold levels of reliable
amplification.
To further confirm viral infectivity, we examined
mock-infected retinal endothelial cells, retinal endothe-
lial cells exposed to heat-killed ZIKV, and retinal endo-
thelial cells exposed to wild-type ZIKV for 96 h (Fig. 3a).
We show positive staining for the 4G2 antibody with
ZIKV wild-type only (Fig. 3b). Virus-infected retinal
Fig. 2 Cellular components of the inner blood-retinal barrier and ZIKV infectivity. Phase contrast images of a an uninfected confluent monolayer of retinal
endothelial cells (a-1), a confluent monolayer of retinal endothelial cells infected with ZIKV 96 h after infection (a-2), immunofluorescence staining of ZIKV-
infected endothelial cells with the Flavivirus 4G2 antibody (a-3), an uninfected confluent monolayer of retinal pericytes (a-4), a confluent monolayer of
retinal pericytes infected with ZIKV 96 h after infection (a-5), immunofluorescence staining of ZIKV-infected pericytes with the Flavivirus 4G2 antibody (a-6),
an uninfected confluent monolayer of Müller cells (a-7), a confluent monolayer of Müller cells infected with ZIKV 96 h after infection (a-8), and
an immunofluorescence staining of ZIKV-infected Müller cells with the Flavivirus 4G2 antibody (a-9). Mock-infected controls of retinal endothelial cells
(a-4), retinal pericytes (a-8), and Müller cells (a-12) stained with the 4G2 antibody. All images were taken on a Nikon TE2000S microscope mounted
with a charge-coupled device (CCD) camera at ×200 total magnification. For fluorescent images, 4′,6-diamidino-2-phenylindole (DAPI) was used to stain
the nuclei blue. b qRT-PCR time course of retinal endothelial cells, retinal pericytes, and Müller cells infected with ZIKV for 24 and 96 h and 8 days after
infection. Mock-infected controls are also shown. All values were normalized to GAPDH. ND indicates no transcriptional expression detected
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endothelial cells showed perinuclear staining with the
Flavivirus 4G2 antibody (Fig. 3b). ZIKV infection of ret-
inal endothelial cells was confirmed by RT-PCR using
ZIKV-specific oligonucleotide primers (Fig. 3c). We
showed semiquantitative RT-PCR amplification of a 364-
bp DNA fragment using ZIKV-specific primers, and no
amplification using cDNA from total RNA obtained
from retinal endothelial cells mock-infected or retinal
endothelial cells exposed to heat-killed ZIKV (Fig. 3c).
GAPDH was amplified as a control represented as a 256-bp
DNA fragment (Fig. 3c). We then examined retinal endo-
thelial cells and controls by qRT-PCR. Our semiquantitative
RT-PCR data that showed specific amplification of ZIKV
transcripts in ZIKV-infected retinal endothelial cells was
validated by qRT-PCR that showed a 13,187-fold increase
in ZIKV mRNA amplification compared to mock-infected
cells and a 3878-fold increase when compared to heat-
killed virus controls (Fig. 3d).
Retinal pigmented epithelial cells of the OBRB are
permissive for ZIKV infectivity and exhibit low-level
cytopathology
The structural integrity of the OBRB is established by the
tight junctions maintained between retinal pigmented
epithelial cells that are proximal to the choroid capillaries
which represent another gateway to the retina. We ex-
posed primary human retinal pigmented epithelial cells to
ZIKV at a MOI of 0.1 for 96 h. In mock-infected cells, we
observed the normal morphology of the retinal pigmented
cells in confluent monolayer cultures (Fig. 4a). Retinal
pigmented cells stained positive for vimentin as suggested
by the supplier (Fig. 4b). Retinal pigmented cells exposed
to ZIKV in 96 h produced characteristic ZIKV cytopathic
effects (Fig. 4c). ZIKA infectivity was confirmed by im-
munofluorescent staining using the 4G2 monoclonal anti-
body after 96 h (Fig. 4d). Virus-infected retinal pigmented
epithelial cells showed a perinuclear staining profile with
the 4G2 antibody (Fig. 4d).
To further confirm viral infectivity, we examined mock-
infected retinal pigmented epithelial cells, retinal pigmen-
ted epithelial cells exposed to heat-killed ZIKV, and retinal
pigmented epithelial cells exposed to wild-type ZIKV for
96 h (Fig. 5a). We found positive staining for the 4G2 anti-
body with ZIKV wild-type only (Fig. 5b). Virus-infected
retinal pigmented epithelial cells showed perinuclear
staining with the Flavivirus 4G2 antibody (Fig. 5b). ZIKV
infection of retinal endothelial cells was confirmed by RT-
PCR using ZIKV-specific oligonucleotide primers (Fig. 5c).
Fig. 3 Retinal endothelial cells infectivity for ZIKV confirmed by RT-PCR. Phase contrast images of a a mock-infected confluent monolayer of retinal
endothelial cells, a confluent monolayer of retinal endothelial cells exposed to heat-killed ZIKV, and retinal endothelial cells exposed to wild-type ZIKV.
b Immunofluorescence staining of ZIKV-infected endothelial cells with the Flavivirus 4G2 antibody. c Semiquantitative RT-PCR amplification of a 364-bp
fragment using ZIKV-specific primers. GAPDH was amplified as a control represented as a 256-bp fragment. Phase and fluorescent images were taken
on a Nikon TE2000S microscope mounted with a charge-coupled device (CCD) camera at ×200 magnification. For fluorescent images, 4′,6-diamidino-
2-phenylindole (DAPI) was used to stain the nuclei blue. d qRT-PCR of ZIKV-infected retinal endothelial cells 96 h after infection. Mock-infected controls
are shown, and all values were normalized to GAPDH
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We show semiquantitative RT-PCR amplification of a
364-bp DNA fragment using ZIKV-specific primers, and
no amplification using cDNA from total RNA obtained
from retinal pigmented epithelial cells mock-infected or
retinal pigmented epithelial cells exposed to heat-killed
ZIKV (Fig. 5c). GAPDH was amplified as a control repre-
sented as a 256-bp DNA fragment (Fig. 5c). We also con-
firmed our semiquantitative RT-PCR data by qRT-PCR.
We observed a 319,512-fold increase in ZIKV mRNA
amplification in retinal pigmented epithelial cells com-
pared to controls (Fig. 5d). All values were normalized to
GAPDH.
Dysregulation of angiogenic and proinflammatory
cytokines in ZIKV-infected retinal endothelial cells
Angiogenic and proinflammatory cytokine and adhesion
molecule levels were examined in retinal endothelial
cells exposed to ZIKV for 96 h (Fig. 6a). In retinal endo-
thelial cells exposed to ZIKV, we observed only a mar-
ginal increase in levels of β2-m, GMCSF, and MCP1; a
moderate increase of ICAM-1, IL-6, and VCAM-1 ex-
pression; but a strong increase of RANTES expression
when to mock-infected controls (Fig. 6a-1–a-8). We
observed moderately higher levels of IL-4 in mock-
infected cells compared to that in ZIKV-infected retinal
endothelial cells (Fig. 6a-4). In retinal endothelial cells
exposed to heat-killed virus, we observed lower levels of
β2-m, GMCSF, ICAM-1, IL-6, MCP1, RANTES, and
VCAM-1 compared to ZIKV-exposed cells (Fig. 6a-1–a-
3, a-5–a-8). Following the significant increase in
RANTES expression levels in retinal endothelial cells by
Luminex analysis, we performed qRT-PCR for RANTES
transcription levels in ZIKV-infected retinal endothelial
cells, retinal pericytes, and Müller cells over a time
course of 24 and 96 h and 8 days after ZIKV infection
(Fig. 6b). In retinal endothelial cells, we observed the
highest level (25-fold) of RANTES expression in ZIKV-
infected cells in 8 days when compared to that in mock-
infected cells (Fig. 6b-1). No significant RANTES
transcriptional expression was observed in 24 and 96 h
when compared to that in mocked-infected cells
(Fig. 6b-1). In retinal pericytes, we observed the highest
level (663-fold) of RANTES transcriptional expression in
ZIKV-infected cells in 96 h after infection (Fig. 6b-2). A
fourfold increase in RANTES expression was observed
in 24 h when compared to that in mock-infected cells,
Fig. 4 Retinal pigmented epithelial cells and ZIKV infectivity. Phase contrast images of a mock-infected confluent monolayer of retinal endothelia cells. b
Immunofluorescence staining of normal retinal pigmented epithelial with an antibody to vimentin. c Phase contrast image of retinal pigmented epithelial
cells infected with ZIKV 96 h after infection. d Immunofluorescence staining of ZIKV-infected retinal pigmented epithelial cells with the 4G2 antibody. All
images were taken on a Nikon TE2000S microscope mounted with a charge-coupled device (CCD) camera at ×200 magnification. For fluorescent images,
4′,6-diamidino-2-phenylindole (DAPI) was used to stain the nuclei blue
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but a reduction in RANTES expression (495-fold) was
observed in 8 days when compared with 96 h in ZIKV-
infected cells (Fig. 6b-2). We observed only a marginal in-
crease in RANTES transcriptional expression in Müller
cells in 24 and 96 h after infection when compared to
ZIKV-infected cells after 8 days and mock-infected cells
(Fig. 6b-3).
ZIKV blood-retinal barrier infection model
In this hypothetical model, ZIKV is shown as blue dots
(Fig. 7). Based on our initial findings, we have developed
a ZIKV blood-retinal barrier infection model [31]. In the
model, we propose that ZIKV enters the IBRB via the
retinal arteries and subsequently the retinal capillaries
(Fig. 7). There is infection and virus amplification in ret-
inal endothelial cells (blue arrow) of the retinal capillar-
ies and retinal pericytes (red arrow) that are abluminal
to retinal endothelial cells allowing the virus to enter the
inner retinal bed. We also propose in the model that
ZIKV enters the OBRB via the choroid capillaries (Fig. 7).
The choroid is a highly vascularized tissue that supplies
blood to the retina, and the choroidal capillary endothe-
lial cells in humans are highly fenestrated which would
allow ZIKV ready access to permissive retinal pigmented
epithelial cells [31] (Fig. 7). Infection and virus
amplification in retinal pigmented epithelial cells (green
arrow) ensue allowing viral dissemination into the prox-
imal retinal bed (Fig. 7).
Discussion
There is no information in the literature that defines tar-
get cell populations in the human eye related to ZIKV-
associated ocular disease. This study provides informa-
tion that is important for understanding ZIKV pathology
in the ocular compartment and identifies important cell
types in both the inner and outer blood-retinal barriers
(IBRB and OBRB) that are permissive for ZIKV infection
and dissemination in the eye. This in vitro study sug-
gests that ZIKV traffics both retinal endothelial cells, ret-
inal pericytes, and retinal pigmented epithelial cells
during infection but does not infect Müller cells. The
highest levels of ZIKV transcription were observed in
retinal pericytes compared in retinal pigmented epithe-
lial cells and retinal endothelial cells. The model we pro-
posed is hypothetical because primary cells in culture
may not behave as cells in ocular tissue and will require
validation in vivo. Cytokine and adhesion molecule pro-
file analysis reveals a marginal increase in the levels of
β2-m, GMCSF, and MCP1 and a moderate increase of
ICAM-1, IL-6, and VCAM-1 expression; however,
Fig. 5 Retinal pigmented epithelial cells infectivity for ZIKV confirmed by RT-PCR. Phase contrast images of: a mock-infected confluent monolayer of retinal
pigmented epithelial cells, a confluent monolayer of retinal pigmented epithelial cells exposed to heat-killed ZIKV, and retinal pigmented epithelial cells
exposed to wild-type ZIKV. b Immunofluorescence staining of ZIKV-infected retinal pigmented epithelial cells with the Flavivirus 4G2 antibody.
c Semiquantitative RT-PCR amplification of a 364-bp fragment using ZIKV-specific primers. GAPDH was amplified as a control represented as a 256-bp
fragment. Phase and fluorescent images were taken on a Nikon TE2000S microscope mounted with a charge-coupled device (CCD) camera at ×200
magnification. For fluorescent images, 4′,6-diamidino-2-phenylindole (DAPI) was used to stain the nuclei blue. d qRT-PCR of ZIKV-infected retinal
pigmented epithelial cells 96 h after infection. Mock-infected controls are shown, and all values were normalized to GAPDH
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Fig. 6 (See legend on next page.)
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significantly higher levels of RANTES expression were
observed in ZIKV-infected cells compared in controls
(Fig. 6a). Recent studies show that patients with ZIKV
infection have high levels of RANTES in their serum
when compared with patients infected with dengue virus
or Chikungunya virus [32]. Upregulation of RANTES
over time would lead to chronic inflammation and re-
cruitment of inflammatory cells in the retinal micro-
environment. The next steps for this study will be to
directly examine eye washing or lacrimal fluid from pa-
tients with ZIKV-associated ocular hyperemia or ocular
tissue from infants who have died of congenital ZIKV
infection to determine viral dissemination patterns and
cytokine expression profiles in vivo.
Conclusions
We have identified primary human retinal endothelial
cells and retinal pericytes of the IBRB and human ret-
inal pigmented epithelial cells of the OBRB as target
cells for ZIKV infection in the eye. We have deter-
mined that ZIKV induces a moderate angiogenic and
proinflammatory cytokine response with the exception
of RANTES in infected retinal endothelial cells that
likely play a major role in ocular inflammation in
(See figure on previous page.)
Fig. 6 a ZIKV induction of proinflammatory and angiogenic cytokines in retinal microvascular endothelial cells after 96 h. Cytokine profiles of
ZIKV-infected retinal endothelial cells by Luminex analysis at 96 h post infection are given. Results from cells exposed to media only are shown as
solid black bars; cells exposed to heat-killed ZIKV are shown as gray bars; and results from cells exposed to the ZIKV are shown as stippled black
bars. Results are included for β2-m (a-1), GMCSF (a-2), ICAM-1 (a-3), IL-4 (a-4), and IL-6 (a-5), MCP-1 (a-6), RANTES (a-7), and VCAM-1 (a-8). Results
are given in picograms per milliliter. The results shown are the averages of replicate samples. b RANTES expression levels by qRT-PCR in retinal
endothelial cells, retinal pericytes, and Müller cells infected with ZIKV over a time course of 24 and 96 h and 8 days after infection. Results are
included for RANTES levels in retinal endothelial cells (b-1), RANTES levels in retinal pericytes (b-2), and RANTES levels in Müller cells (b-3). Colored
bars indicate the normalized fold transcriptional expression of RANTES compared with mock-infected control cells. ND indicates no transcriptional
expression detected
Fig. 7 ZIKV blood-retinal barrier infection model. A hypothetical model of ZIKV infection and dissemination from inner and outer blood-retinal
barriers into the retinal bed. ZIKV is shown as blue dots. ZIKV infects and disseminates from the retinal endothelial cells and retinal pericytes of the
IBRB and the retinal pigmented epithelial cells of the OBRB. The blue arrow indicates the retinal endothelial cells; the red arrow shows the retinal
pericytes in the IBRB; and the retinal pigmented epithelial cells in the OBRB are shown by the green arrow. ILM internal limiting membrane, MLM
middle limiting membrane, RPE retinal pigmented epithelial cells
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acute ZIKV ocular disease. The hypothetical model
we proposed based on our findings suggests that
ZIKV disseminates throughout the retinal bed via the
retinal arteries and infects retinal capillary endothelial
cells and retinal pericytes of the IBRB and traffics the
choroid capillaries to infect retinal pigmented epithe-
lial cells in the OBRB.
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